Learning Center

Learning Center

September 2027 - Quality Bone Densitometry: Performance, Interpretation, and Clinical Application for Clinicians

Includes Multiple Live Events. The next is on 09/11/2027 at 10:00 AM (EDT)

  • Register
    • Non-Member - $975
    • Full Member - $675
    • Clinician Member - $675
    • Technologist Member - $675
    • Resident/Student/Fellow/Retired Membership - $675
    • MOC Only - $975
    • Community Member - $675
    • Professional Member - $675

Course Date

September 11 & 12, 2027.


Course Description

The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients.


Target Audience

The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD Quality Bone Densitometry for Technologists course.


Learning Objectives

After attending the course, participants should be better prepared to:

  1. Describe appropriate clinical evaluation of patients at risk for fragility fracture.
  2. Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD. 
  3. Recognize errors in DXA analysis and reporting. 
  4. Explain new and emerging guidelines that provide evidence-based information regarding skeletal health. 
  5. Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.

Method of Participation

This activity will be offered live streamed via Zoom, allowing the learner to watch and ask questions in a live format on September 11 & 12, 2027. The course will NOT be recorded for future viewing, so attendees must be present during the scheduled times. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.

Rates

image


Cancellation Policy

Attendee Cancellation Policy All changes in registration must be made in writing to [email protected]. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

ACCME Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and ISCD. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

image

AMA PRA Category 1 Credit(s)™

This activity is under review for accreditation by Amedco LLC targeting a maximum of 13.00 AMA PRA Category 1 CreditsTM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Deadline to Claim Credit

Participants will have 90 days from the live activity end date to complete the activity survey and claim continuing education credit. The last day to claim credit or access materials for this course is December 14, 2027 @ 11:00pm EST.

Schedule - Saturday, September 11, 2027 - All times Eastern Time (NYC/USA)

image


Schedule - Sunday, September 12, 2027 - All times Eastern Time (NYC/USA)

image



S. Bobo Tanner, MD, CCD

S. Bobo Tanner, MD, CCD

Director

Vanderbilt University Medical Center Osteoporosis Clinic

S. Bobo Tanner, MD, graduated cum laude from Harvard University in Cambridge, Massachusetts, with a BA in History and Science, and received his medical degree with honors from Bowman Gray Medical School of Wake Forest University, Winston-Salem, North Carolina. 
He completed his Internal Medicine residency and fellowships in Rheumatology and in Allergy/Immunology at Vanderbilt University Hospital in Nashville TN.
He founded and is the Director of the Vanderbilt Osteoporosis Clinic in the Division of Rheumatology.
He is a past president and board member of the International Society for Clinical Densitometry (ISCD) where he teaches the Quality Bone Density course and helps develops professional guidelines for the use and reporting of DXA. He was recognized as the ISCD Clinician of the Year in 2007 and received the President’s Award from the Tennessee Rheumatology Society in 2017. He was awarded the Lifetime Achievement Award by the Irish Dual-energy X-ray Absorptiometry Society in 2024 and the Paul Miller MD Educator of the Year Award at the Santa Fe Bone Symposium, 24th Annual Meeting in 2024.

Vidushi Sood, MD

Vidushi Sood, MD

Endocrinologist and Clinical Associate Professor

UW Health, Department of Medicine at the University of Wisconsin School of Medicine and Public Health

Vidushi Sood, MD, is a UW Health endocrinologist and a clinical associate professor in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health. She cares for patients with a range of hormone-related disorders and bone health issues.

Dr. Sood commonly treats hormonal conditions originating in the thyroid, adrenal and pituitary glands. These can include diabetes, thyroid and pituitary disease, beta thyroid disease (genetic condition that affects hormones), ovarian and testicular disease and bone health disorders. She has special clinical interests in osteoporosis (bone weakening) and polycystic ovarian syndrome, or PCOS (ovaries produce unusually high levels of male sex hormones, which can make getting pregnant challenging).

Dr. Sood personalizes care to meet each patient’s needs. She listens carefully to understand their concerns and goals and offers education about conditions and treatment options. She takes a comprehensive, holistic approach to care, addressing all her patients’ concerns to improve their health and wellness. She enjoys helping people feel better and finds it particularly rewarding to help people sleep better or become pregnant, for example.

Christopher Shuhart, MD, MHA, CCD

Christopher Shuhart, MD, MHA, CCD

Instructor, Department of Family Medicine and Geriatrics Fellowship

Swedish Medical Center

Dr. Shuhart was the founder and director of the Bone Health and Osteoporosis Center at Swedish Medical Group in Seattle, Washington. He is Past-President of the International Society for Clinical Densitometry (ISCD) 2019-2020. He is a co-author on the ISCD’s 2016 publication of “Best Practices” in the Journal of Clinical Densitometry, and was Co-Chair and Executive Author for the 2019 and 2023 ISCD Position Development Conferences.

Dr. Shuhart is now retired from clinical practice but continues to be active in teaching and training of residents, fellows and APC’s. 

Dr. Shuhart received his medical degree from Dartmouth Medical School in 1987, and his Masters in Health Administration from the University of Washington in 2009. He is board certified in Family Medicine since 1990.

image

Statement of Independence

The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity.

Disclaimer

The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.

Disclosure of Unlabeled Use

This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.

Privacy & Confidentiality Statement

The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties.

Attendance Cancellation Policy

All changes in registration must be made in writing to [email protected]. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.

Course Changes or Cancellations

ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.

Components visible upon registration.